These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16421805)

  • 1. Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
    Brummitt CF
    Clin Infect Dis; 2006 Feb; 42(4):575. PubMed ID: 16421805
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
    Ghislanzoni M; Cusini M; Zerboni R; Alessi E
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):887-9. PubMed ID: 16898926
    [No Abstract]   [Full Text] [Related]  

  • 3. Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
    Tandon S; Singh J; Sinha S; Sharma DP
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28261899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review.
    Perkins N; Nisbet M; Thomas M
    Sex Transm Infect; 2011 Jun; 87(4):292-5. PubMed ID: 21406577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection.
    Gilbert J; Drehs MM; Weinberg JM
    Arch Dermatol; 2001 Aug; 137(8):1015-7. PubMed ID: 11493093
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labeling updates to genital herpes drug.
    FDA Consum; 2003; 37(6):3. PubMed ID: 14983803
    [No Abstract]   [Full Text] [Related]  

  • 8. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.
    Lebrun-Vignes B; Bouzamondo A; Dupuy A; Guillaume JC; Lechat P; Chosidow O
    J Am Acad Dermatol; 2007 Aug; 57(2):238-46. PubMed ID: 17416440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making the most of episodic antiviral therapy for genital herpes.
    Patel R
    Sex Health; 2008 Sep; 5(3):213-4. PubMed ID: 18828250
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful use of valciclovir in a case of recurrent urticaria associated with genital herpes.
    Khunda A; Kawsar M; Parkin JM; Forster GE
    Sex Transm Infect; 2002 Dec; 78(6):468. PubMed ID: 12473820
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral treatment of genital herpes.
    O'Mahony C
    Int J STD AIDS; 2004 Dec; 15(12):847-8. PubMed ID: 15601498
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
    Kimberlin DW; Baley J; ;
    Pediatrics; 2013 Feb; 131(2):383-6. PubMed ID: 23378604
    [No Abstract]   [Full Text] [Related]  

  • 15. Genital herpes.
    Jungmann E
    Clin Evid; 2005 Jun; (13):1987-2001. PubMed ID: 16135318
    [No Abstract]   [Full Text] [Related]  

  • 16. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
    Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
    Leone PA; Trottier S; Miller JM
    Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Valaciclovir in the treatment of initial infection by genital herpes virus: comparative study].
    García A; García S; Sánchez JA; García I; Lanchares JL
    Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):15-8. PubMed ID: 11256241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.